Golubchik, Tanya
12 papers on CoChatORCID 0000-0003-2765-9828
Most cited papers
- Verified
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,097
- Verified
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchEvolution and Genetic Dynamics
Cited by 1,006
- Verified
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., et al. (2022) · The Lancet Infectious Diseases
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 803
- Verified
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., Cantoni, D., Scott, S., Logan, N., Ashraf, S., et al. (2022) · Nature Microbiology
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 785
- Verified
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., Silacci-Fregni, C., et al. (2021) · Nature
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 728
- Verified
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., et al. (2021) · The Lancet
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 603
- Verified
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 328
- Verified
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., et al. (2021) · The Lancet Public Health
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies
Cited by 304
- Verified
Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage
Golubchik, T., Batty, E. M., Miller, R. R., Farr, H., Young, B. C., Larner-Svensson, H., Fung, R., Godwin, H., Knox, K., Votintseva, A., et al. (2013) · PLoS ONE
Antimicrobial Resistance in StaphylococcusEvolution and Genetic Dynamics
Cited by 212
- Verified
Recombinational Switching of the Clostridium difficile S-Layer and a Novel Glycosylation Gene Cluster Revealed by Large-Scale Whole-Genome Sequencing
Dingle, K. E., Didelot, X., Ansari, M. A., Eyre, D. W., Vaughan, A., Griffiths, D., Ip, C. L. C., Batty, E. M., Golubchik, T., Bowden, R., et al. (2013) · The Journal of Infectious Diseases
Clostridium difficile and Clostridium perfringens researchEscherichia coli research studies
Cited by 104
- Verified
Early analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein
Golubchik, T., Lythgoe, K. A., Hall, M., Ferretti, L., Fryer, H. R., MacIntyre-Cockett, G., de Cesare, M., Trebes, A., Piazza, P., Buck, D., et al. (2021) · medRxiv
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies
Cited by 45
- Verified · note
Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)
Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B. J., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., et al. (2021) · SSRN Electronic Journal
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free